Last updated : July 27, 2026 8:26 am
Over the years, the medical imaging and diagnostics sector has transitioned primarily from the use of standalone diagnostic equipment to the use of integrated data-driven ecosystems
In an exclusive interview with Rahul Koul, Editor, Indian Pharma Post, Ajay Kandhari, Managing Director, DSS Imagetech shared his insights on the company’s journey so far, growth drivers, latest industry trends, competition and much more.
DSS Imagetech has been a prominent player in diagnostic and imaging solutions for several decades. How has the company's journey evolved over the years?
DSS Imagetech began as a provider of advanced diagnostic and imaging technologies and has steadily evolved into a comprehensive healthcare solutions partner. Over the years, we have expanded our portfolio across microscopy, clinical diagnostics, medical equipment, and research & development, enabling healthcare providers to deliver more accurate, efficient, and patient-centric care.
What are the most significant transformations you have witnessed in the medical imaging and diagnostics industry during your career?
The industry has shifted from standalone diagnostic equipment to integrated, data-driven ecosystems. Advances in digital imaging, automation, AI-assisted diagnostics, and precision medicine have significantly improved diagnostic accuracy, speed, and clinical outcomes. There is also a growing emphasis on early diagnosis, preventive healthcare and personalized treatment pathways.
Over the years, the medical imaging and diagnostics sector has transitioned primarily from the use of standalone diagnostic equipment to the use of integrated data-driven ecosystems. There have been substantial improvements in imaging accuracy and clinical outcomes due to technological advances such as digital imaging, automation, AI-assisted diagnostics, and precision medicine have significantly improved diagnostic accuracy, speed, and clinical outcomes. There has also been an increasing emphasis on early detection of disease, preventive healthcare, and personalised treatments.
What growth segments are expected to contribute most significantly to DSS Imagetech's business in the coming years?
The DSS Imagetech's business growth segments are expected to be most heavily influenced by advanced imaging, digital pathology, molecular diagnostics, AI-enabled diagnostic solutions, and reproductive care. The IVF sector, in particular, continues to see significant momentum, with the help of increased awareness, technological improvements, and acceptance of new treatments around the globe continuing to drive strong growth.
How is the company preparing for the increasing convergence of AI, automation, and data-driven healthcare?
At Hana Health by DSS Imagetech, we believe that the future of healthcare lies at the intersection of artificial intelligence, automation, and data-driven clinical decision-making. As a company focused on advancing reproductive healthcare and fertility solutions, we are continuously investing in technologies that improve accuracy, efficiency, and patient outcomes. Through advanced technologies such as AI-enabled embryo assessment and time-lapse incubation systems, clinicians can monitor embryo development continuously, analyse large volumes of developmental data, and make more informed embryo selection decisions. This not only enhances precision but also helps standardise processes and reduce subjectivity in fertility treatments.
Automation is equally important in creating efficient and consistent laboratory environments. By incorporating automated workflows and intelligent monitoring systems, we help fertility specialists optimise operational efficiency while maintaining the highest standards of care. Beyond fertility care, we recognise the growing importance of healthcare data in driving personalised treatment pathways and improving clinical outcomes. By leveraging data analytics and AI-driven insights, healthcare providers can better understand patient needs, predict outcomes, and deliver more tailored interventions.
As healthcare continues to evolve, Hana Health remains committed to bringing cutting-edge AI and automation technologies to India, enabling clinicians to make evidence-based decisions while improving the overall patient experience and advancing the future of reproductive medicine.
How do you assess the competitive landscape in India's diagnostic technology market, and what differentiates DSS Imagetech?
The growth of the market is increasingly fast because of the continuous advances in innovations in technology and the rising health-related needs. What really sets DSS Imagetech apart from others is its ability to combine a diversified mix of globally recognized technologies with strong technical expertise, service support, and deep customer relationships cultivated over decades.
How do you balance innovation, affordability, and accessibility in a price-sensitive healthcare market like India?
Our objective is to make innovation translate into improved patient outcomes across a large number of patients. We work with global partners as well as healthcare providers to bring new technologies that are clinically relevant, operationally efficient, and financially viable into clinical practice. The goal is to improve the accessibility of advanced diagnostics while not sacrificing the quality of those services.